Recently, there have been rumors that speaker fees may be leaving the pharmaceutical industry. If true, wouldn't that catch many people off guard? But it is not entirely unexpected. After all the discussion, the industry still has to move toward compliant marketing.
However, when the life sciences industry tries to move toward compliant marketing, it often faces several huge problems that are difficult to solve:
Consistency between strategy and execution
There is a major gap between strategies formulated by marketing and medical teams and execution by frontline teams.
Subjective and scattered decision-making
Actual decision-making power sits with frontline team members, who decide what actions to take based on their personal understanding and judgment of the overall strategy.
Difficulty obtaining real customer data
Frontline teams enter and feed back data through various tools such as CRM. Often, data is entered merely for the sake of entry and struggles to reflect real customer information.
This may sound abstract, so let me give an example:
I (marketing or medical) want an apple (customer), but I cannot name the apple. I can only describe it with broad adjectives and ask my friends (frontline teams) to help me find it.
"I want something round, red, edible, and sweet..."
But once my friends receive the message and interpret it themselves, the story gradually goes off track.
"Round, sweet, and edible. Do you mean a pear?"
"Round and edible. Maybe an egg?"
"Round and red. Are you looking for Yuan Hong? Then it must be a ping-pong paddle."
See? Even finding an apple can become like this, let alone multi-team, omnichannel marketing collaboration. Uncoordinated multi-touch marketing often gives customers a negative impression. Should we choose to do nothing, or do more and make more mistakes? That is a truly frustrating choice.
NICE, a next-generation closed-loop digital intelligence precision marketing toolkit, was launched to solve these problems.
NICE includes a customer data center, UCH (Unified Customer Hub), customer tag platform, content management center, and strategy center. It also connects meeting systems and automated distribution channels. It enables precise specification and one-click distribution of marketing and medical strategies, while also supporting precise strategy development, audience selection, content matching, activity matching, resource allocation, instruction delivery, and data feedback across meetings, content, clinical trials, and visits. It is a powerful tool for marketing and medical departments to drive business growth. It greatly reduces decision-making costs, shortens decision cycles, strengthens consistency in strategy execution, improves customer experience, and accelerates the customer journey.
In short,
- NICE breaks down omnichannel data barriers and enables companies to describe and stage customers based on their real situations.
- It helps enterprises uncover growth opportunities from data and turn marketing strategies into clear instructions for frontline teams.
- It creates insight-driven, customer-journey-centered, data-closed-loop, compliant precision marketing that drives business growth.
At this point, it is clear that NICE is a mature product that supports private deployment. It includes the digital platforms mentioned above and the integrated algorithms behind them. It has already been fully deployed and used by multiple benchmark enterprises, received strong praise, and delivered significant business value: MeDomino Helps a European Pharmaceutical Company Achieve Integrated Strategy Execution [click to read]
Why does the life sciences industry need NICE? What business value can NICE bring to the life sciences industry? Please follow our upcoming articles, where we will also share real MeDomino cases. Stay tuned.
